Steven Sung
Foot & Ankle Surgery · Auburn, WANPI 1346670999
Payments from drug & device makers
Across 51 payments — averaging $86.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Summit Surgical Corp.$1K
- Treace Medical Concepts, Inc.$533
- Smith+Nephew$314
- Organogenesis Inc.$147
- Fusion Orthopedics USA, LLC$103
- plus $417 from 13 others
What the payments were for
- Travel & lodging$42410%
- Food & beverage$1,58336%
- Education$2,40054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,662 |
| Summit Surgical Corp. | 2 | $1,232 |
| Treace Medical Concepts, Inc. | 11 | $533 |
| Smith+Nephew | 11 | $314 |
| Organogenesis Inc. | 5 | $147 |
| Fusion Orthopedics USA, LLC | 1 | $103 |
| Medtronic | 2 | $95 |
| Reprise Biomedical, Inc. | 2 | $49 |
| Zimmer Biomet | 1 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Arthrosurface Incorporated | 1 | $29 |
| Stryker | 1 | $26 |
| Heron Therapeutics, Inc. | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| Mimedx Group, Inc. | 1 | $24 |
| Next Science LLC | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$248
- GRAFIX PL$149
How this compares
$4,408 in reported general payments places this provider in the 65th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 56 | $2,678 |
| Ketoconazole | 68 | $1,601 |
| Ammonium Lactate | 22 | $383 |
| Cephalexin | 49 | $366 |
| Gabapentin | 22 | $269 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $212 |
| Clindamycin Hcl | 11 | $59 |
| Meloxicam | 12 | $38 |
| Naproxen | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Auburn
- Edward LeeAuburn$14K
- Jeffrey ChristensenEverett$884K
- David DalstromSeattle$497K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.